Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mohammad Alyami

Showing results (11-20 of 44) with videos related to

Pageof 5
Sort By:
Indian Journal of Surgical Oncology|March 20, 2019
The Current Status of Peritoneal Surface Oncology in Saudi ArabiaMohammad Alyami, Frederic Mercier, Thamer Bin Traiki, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|May 17, 2019
Oxaliplatin use in pressurized intraperitoneal aerosol chemotherapy (PIPAC) is safe and effective: A multicenter studyOlivia Sgarbura, Martin Hübner, Mohammad Alyami, et al.
Surgical Endoscopy|December 4, 2019
Long-term results of laparoscopic cytoreductive surgery and HIPEC for the curative treatment of low-grade pseudomyxoma peritonei and multicystic mesotheliomaFrederic Mercier, Guedj Jeremie, Mohammad Alyami, et al.
Cancer Chemotherapy and Pharmacology|December 5, 2018
Severe hypersensitivity reactions to platinum compounds post-pressurized intraperitoneal aerosol chemotherapy (PIPAC): first literature reportMatthieu Siebert, Mohammad Alyami, Frederic Mercier, et al.
The Lancet. Oncology|July 4, 2019
Pressurised intraperitoneal aerosol chemotherapy: rationale, evidence, and potential indicationsMohammad Alyami, Martin Hübner, Fabian Grass, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|June 21, 2020
Pressurized intraperitoneal aerosol chemotherapy (PIPAC) for unresectable peritoneal metastasis from gastric cancerMohammad Alyami, Pierre-Emmanuel Bonnot, Frederic Mercier, et al.
Cancers|October 27, 2022
Assessment of Treatment Response after Pressurized Intra-Peritoneal Aerosol Chemotherapy (PIPAC) for Appendiceal Peritoneal MetastasesS P Somashekhar, Julio Abba, Olivia Sgarbura, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|October 2, 2017
Multicentric initial experience with the use of the pressurized intraperitoneal aerosol chemotherapy (PIPAC) in the management of unresectable peritoneal carcinomatosisMohammad Alyami, Johan Gagniere, Olivia Sgarbura, et al.
Nature Reviews. Clinical Oncology|September 7, 2022
Advances in the management of peritoneal malignanciesVahan Kepenekian, Aditi Bhatt, Julien Péron, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|March 28, 2019
Pressurized intraperitoneal aerosol chemotherapy (PIPAC) in association with systemic chemotherapy and bevacizumab, evaluation of safety and feasibility. A single center comparative studyMatthieu Siebert, Mohammad Alyami, Frederic Mercier, et al.
Pageof 5

Showing results (11-20 of 44) with videos related to

Sort By:
Pageof 5
Indian Journal of Surgical Oncology|March 20, 2019
The Current Status of Peritoneal Surface Oncology in Saudi ArabiaMohammad Alyami, Frederic Mercier, Thamer Bin Traiki, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|May 17, 2019
Oxaliplatin use in pressurized intraperitoneal aerosol chemotherapy (PIPAC) is safe and effective: A multicenter studyOlivia Sgarbura, Martin Hübner, Mohammad Alyami, et al.
Surgical Endoscopy|December 4, 2019
Long-term results of laparoscopic cytoreductive surgery and HIPEC for the curative treatment of low-grade pseudomyxoma peritonei and multicystic mesotheliomaFrederic Mercier, Guedj Jeremie, Mohammad Alyami, et al.
Cancer Chemotherapy and Pharmacology|December 5, 2018
Severe hypersensitivity reactions to platinum compounds post-pressurized intraperitoneal aerosol chemotherapy (PIPAC): first literature reportMatthieu Siebert, Mohammad Alyami, Frederic Mercier, et al.
The Lancet. Oncology|July 4, 2019
Pressurised intraperitoneal aerosol chemotherapy: rationale, evidence, and potential indicationsMohammad Alyami, Martin Hübner, Fabian Grass, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|June 21, 2020
Pressurized intraperitoneal aerosol chemotherapy (PIPAC) for unresectable peritoneal metastasis from gastric cancerMohammad Alyami, Pierre-Emmanuel Bonnot, Frederic Mercier, et al.
Cancers|October 27, 2022
Assessment of Treatment Response after Pressurized Intra-Peritoneal Aerosol Chemotherapy (PIPAC) for Appendiceal Peritoneal MetastasesS P Somashekhar, Julio Abba, Olivia Sgarbura, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|October 2, 2017
Multicentric initial experience with the use of the pressurized intraperitoneal aerosol chemotherapy (PIPAC) in the management of unresectable peritoneal carcinomatosisMohammad Alyami, Johan Gagniere, Olivia Sgarbura, et al.
Nature Reviews. Clinical Oncology|September 7, 2022
Advances in the management of peritoneal malignanciesVahan Kepenekian, Aditi Bhatt, Julien Péron, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|March 28, 2019
Pressurized intraperitoneal aerosol chemotherapy (PIPAC) in association with systemic chemotherapy and bevacizumab, evaluation of safety and feasibility. A single center comparative studyMatthieu Siebert, Mohammad Alyami, Frederic Mercier, et al.
Pageof 5